Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1992 Dec;77(4):488–493.

Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone.

A Hartnell 1, A B Kay 1, A J Wardlaw 1
PMCID: PMC1421652  PMID: 1493920

Abstract

Eosinophil function is regulated by several cytokines, including interleukin-3 (IL-3), IL-5 and granulocyte-macrophage colony-stimulating factor (GM-CSF). Culture of human eosinophils with IL-3 produced a marked, dose-dependent up-regulation of CR3 expression. This was maximal after 1 day in culture and dependent on protein and RNA synthesis, as demonstrated by inhibition with cycloheximide and actinomycin D, respectively. IL-5 and GM-CSF had a similar effect on eosinophil complement receptor type 3 (CR3) expression, but the maximal response to IL-5 was always less than to IL-3 or GM-CSF. Dexamethasone inhibited the Il-3-induced up-regulation of CR3 expression in a dose-dependent manner, with an IC50 of 5 x 10(-8) M. This study demonstrates the effect of IL-3, IL-5 and GM-CSF on eosinophil CR3 expression and confirms the capacity of eosinophils to modify their phenotype through de novo protein synthesis. This process could be inhibited by physiological concentrations of glucocorticoids, thus providing an additional mechanism for their mode of action in allergic disease.

Full text

PDF
488

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnaout M. A. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood. 1990 Mar 1;75(5):1037–1050. [PubMed] [Google Scholar]
  2. Bainton D. F., Miller L. J., Kishimoto T. K., Springer T. A. Leukocyte adhesion receptors are stored in peroxidase-negative granules of human neutrophils. J Exp Med. 1987 Dec 1;166(6):1641–1653. doi: 10.1084/jem.166.6.1641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Balkwill F. R., Burke F. The cytokine network. Immunol Today. 1989 Sep;10(9):299–304. doi: 10.1016/0167-5699(89)90085-6. [DOI] [PubMed] [Google Scholar]
  4. Berger M., O'Shea J., Cross A. S., Folks T. M., Chused T. M., Brown E. J., Frank M. M. Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J Clin Invest. 1984 Nov;74(5):1566–1571. doi: 10.1172/JCI111572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bischoff S. C., Brunner T., De Weck A. L., Dahinden C. A. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med. 1990 Dec 1;172(6):1577–1582. doi: 10.1084/jem.172.6.1577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Buckle A. M., Hogg N. The effect of IFN-gamma and colony-stimulating factors on the expression of neutrophil cell membrane receptors. J Immunol. 1989 Oct 1;143(7):2295–2301. [PubMed] [Google Scholar]
  7. Capron M., Kazatchkine M. D., Fischer E., Joseph M., Butterworth A. E., Kusnierz J. P., Prin L., Papin J. P., Capron A. Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against schistosomes. J Immunol. 1987 Sep 15;139(6):2059–2065. [PubMed] [Google Scholar]
  8. Charlesworth E. N., Kagey-Sobotka A., Schleimer R. P., Norman P. S., Lichtenstein L. M. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen. J Immunol. 1991 Jan 15;146(2):671–676. [PubMed] [Google Scholar]
  9. Desreumaux P., Janin A., Colombel J. F., Prin L., Plumas J., Emilie D., Torpier G., Capron A., Capron M. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med. 1992 Jan 1;175(1):293–296. doi: 10.1084/jem.175.1.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Diamond M. S., Staunton D. E., de Fougerolles A. R., Stacker S. A., Garcia-Aguilar J., Hibbs M. L., Springer T. A. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol. 1990 Dec;111(6 Pt 2):3129–3139. doi: 10.1083/jcb.111.6.3129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fearon D. T., Collins L. A. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J Immunol. 1983 Jan;130(1):370–375. [PubMed] [Google Scholar]
  12. Fischer E., Capron M., Prin L., Kusnierz J. P., Kazatchkine M. D. Human eosinophils express CR1 and CR3 complement receptors for cleavage fragments of C3. Cell Immunol. 1986 Feb;97(2):297–306. doi: 10.1016/0008-8749(86)90400-4. [DOI] [PubMed] [Google Scholar]
  13. Gordon J. R., Burd P. R., Galli S. J. Mast cells as a source of multifunctional cytokines. Immunol Today. 1990 Dec;11(12):458–464. doi: 10.1016/0167-5699(90)90176-a. [DOI] [PubMed] [Google Scholar]
  14. Hallsworth M. P., Litchfield T. M., Lee T. H. Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils. Immunology. 1992 Feb;75(2):382–385. [PMC free article] [PubMed] [Google Scholar]
  15. Hartnell A., Moqbel R., Walsh G. M., Bradley B., Kay A. B. Fc gamma and CD11/CD18 receptor expression on normal density and low density human eosinophils. Immunology. 1990 Feb;69(2):264–270. [PMC free article] [PubMed] [Google Scholar]
  16. Her E., Frazer J., Austen K. F., Owen W. F., Jr Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest. 1991 Dec;88(6):1982–1987. doi: 10.1172/JCI115524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hirai K., Morita Y., Misaki Y., Ohta K., Takaishi T., Suzuki S., Motoyoshi K., Miyamoto T. Modulation of human basophil histamine release by hemopoietic growth factors. J Immunol. 1988 Dec 1;141(11):3958–3964. [PubMed] [Google Scholar]
  18. Jones D. H., Anderson D. C., Burr B. L., Rudloff H. E., Smith C. W., Krater S. S., Schmalstieg F. C. Quantitation of intracellular Mac-1 (CD11b/CD18) pools in human neutrophils. J Leukoc Biol. 1988 Dec;44(6):535–544. doi: 10.1002/jlb.44.6.535. [DOI] [PubMed] [Google Scholar]
  19. Kay A. B., Ying S., Varney V., Gaga M., Durham S. R., Moqbel R., Wardlaw A. J., Hamid Q. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med. 1991 Mar 1;173(3):775–778. doi: 10.1084/jem.173.3.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kita H., Ohnishi T., Okubo Y., Weiler D., Abrams J. S., Gleich G. J. Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med. 1991 Sep 1;174(3):745–748. doi: 10.1084/jem.174.3.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Koenderman L., Tool A. T., Roos D., Verhoeven A. J. Priming of the respiratory burst in human eosinophils is accompanied by changes in signal transduction. J Immunol. 1990 Dec 1;145(11):3883–3888. [PubMed] [Google Scholar]
  22. Kurihara K., Wardlaw A. J., Moqbel R., Kay A. B. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021. J Allergy Clin Immunol. 1989 Jan;83(1):83–90. doi: 10.1016/0091-6749(89)90480-6. [DOI] [PubMed] [Google Scholar]
  23. Lamas A. M., Leon O. G., Schleimer R. P. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. J Immunol. 1991 Jul 1;147(1):254–259. [PubMed] [Google Scholar]
  24. Lopez A. F., Begley C. G., Williamson D. J., Warren D. J., Vadas M. A., Sanderson C. J. Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells. J Exp Med. 1986 May 1;163(5):1085–1099. doi: 10.1084/jem.163.5.1085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lopez A. F., Dyson P. G., To L. B., Elliott M. J., Milton S. E., Russell J. A., Juttner C. A., Yang Y. C., Clark S. C., Vadas M. A. Recombinant human interleukin-3 stimulation of hematopoiesis in humans: loss of responsiveness with differentiation in the neutrophilic myeloid series. Blood. 1988 Nov;72(5):1797–1804. [PubMed] [Google Scholar]
  26. Lopez A. F., Eglinton J. M., Gillis D., Park L. S., Clark S., Vadas M. A. Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7022–7026. doi: 10.1073/pnas.86.18.7022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lopez A. F., Sanderson C. J., Gamble J. R., Campbell H. D., Young I. G., Vadas M. A. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med. 1988 Jan 1;167(1):219–224. doi: 10.1084/jem.167.1.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lopez A. F., To L. B., Yang Y. C., Gamble J. R., Shannon M. F., Burns G. F., Dyson P. G., Juttner C. A., Clark S., Vadas M. A. Stimulation of proliferation, differentiation, and function of human cells by primate interleukin 3. Proc Natl Acad Sci U S A. 1987 May;84(9):2761–2765. doi: 10.1073/pnas.84.9.2761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lopez A. F., Williamson D. J., Gamble J. R., Begley C. G., Harlan J. M., Klebanoff S. J., Waltersdorph A., Wong G., Clark S. C., Vadas M. A. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest. 1986 Nov;78(5):1220–1228. doi: 10.1172/JCI112705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Moqbel R., Hamid Q., Ying S., Barkans J., Hartnell A., Tsicopoulos A., Wardlaw A. J., Kay A. B. Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med. 1991 Sep 1;174(3):749–752. doi: 10.1084/jem.174.3.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Neuman E., Huleatt J. W., Jack R. M. Granulocyte-macrophage colony-stimulating factor increases synthesis and expression of CR1 and CR3 by human peripheral blood neutrophils. J Immunol. 1990 Nov 15;145(10):3325–3332. [PubMed] [Google Scholar]
  32. O'Shea J. J., Brown E. J., Seligmann B. E., Metcalf J. A., Frank M. M., Gallin J. I. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J Immunol. 1985 Apr;134(4):2580–2587. [PubMed] [Google Scholar]
  33. Owen W. F., Jr, Rothenberg M. E., Silberstein D. S., Gasson J. C., Stevens R. L., Austen K. F., Soberman R. J. Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts. J Exp Med. 1987 Jul 1;166(1):129–141. doi: 10.1084/jem.166.1.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Peterson A. P., Altman L. C., Hill J. S., Gosney K., Kadin M. E. Glucocorticoid receptors in normal human eosinophils: comparison with neutrophils. J Allergy Clin Immunol. 1981 Sep;68(3):212–217. doi: 10.1016/0091-6749(81)90186-x. [DOI] [PubMed] [Google Scholar]
  35. Robinson D. S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A. M., Corrigan C., Durham S. R., Kay A. B. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 1992 Jan 30;326(5):298–304. doi: 10.1056/NEJM199201303260504. [DOI] [PubMed] [Google Scholar]
  36. Rothenberg M. E., Owen W. F., Jr, Silberstein D. S., Woods J., Soberman R. J., Austen K. F., Stevens R. L. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest. 1988 Jun;81(6):1986–1992. doi: 10.1172/JCI113547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rothenberg M. E., Petersen J., Stevens R. L., Silberstein D. S., McKenzie D. T., Austen K. F., Owen W. F., Jr IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J Immunol. 1989 Oct 1;143(7):2311–2316. [PubMed] [Google Scholar]
  38. Schleimer R. P., Derse C. P., Friedman B., Gillis S., Plaut M., Lichtenstein L. M., MacGlashan D. W., Jr Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. J Immunol. 1989 Aug 15;143(4):1310–1317. [PubMed] [Google Scholar]
  39. Schleimer R. P. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma. Am Rev Respir Dis. 1990 Feb;141(2 Pt 2):S59–S69. [PubMed] [Google Scholar]
  40. Shalit M., Von Allmen C., Atkins P. C., Zweiman B. Platelet activating factor increases expression of complement receptors on human neutrophils. J Leukoc Biol. 1988 Sep;44(3):212–217. doi: 10.1002/jlb.44.3.212. [DOI] [PubMed] [Google Scholar]
  41. Silberstein D. S., Owen W. F., Gasson J. C., DiPersio J. F., Golde D. W., Bina J. C., Soberman R., Austen K. F., David J. R. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J Immunol. 1986 Nov 15;137(10):3290–3294. [PubMed] [Google Scholar]
  42. Smith S. F. A potential mechanism for some anti-inflammatory effects of the glucocorticoids? Respir Med. 1990 Nov;84(6):435–436. doi: 10.1016/s0954-6111(08)80105-9. [DOI] [PubMed] [Google Scholar]
  43. Tai P. C., Sun L., Spry C. J. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Clin Exp Immunol. 1991 Aug;85(2):312–316. doi: 10.1111/j.1365-2249.1991.tb05725.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Vadas M. A., David J. R., Butterworth A., Pisani N. T., Siongok T. A. A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. J Immunol. 1979 Apr;122(4):1228–1236. [PubMed] [Google Scholar]
  45. Valerius T., Repp R., Kalden J. R., Platzer E. Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action. J Immunol. 1990 Nov 1;145(9):2950–2958. [PubMed] [Google Scholar]
  46. Wallen N., Kita H., Weiler D., Gleich G. J. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol. 1991 Nov 15;147(10):3490–3495. [PubMed] [Google Scholar]
  47. Walsh G. M., Hartnell A., Wardlaw A. J., Kurihara K., Sanderson C. J., Kay A. B. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology. 1990 Oct;71(2):258–265. [PMC free article] [PubMed] [Google Scholar]
  48. Weisbart R. H., Golde D. W., Clark S. C., Wong G. G., Gasson J. C. Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. 1985 Mar 28-Apr 3Nature. 314(6009):361–363. doi: 10.1038/314361a0. [DOI] [PubMed] [Google Scholar]
  49. Zeiger R. S., Colten H. R. Histaminase release from human eosinophils. J Immunol. 1977 Feb;118(2):540–543. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES